In this newsletter we talk about eight of our investees:

  • Novartis acquires Uniseed investee company, Spinifex Pharmaceuticals,  for US$200m plus milestone payments.
  • Hatchtech M&A process to commercialize Xeglyze™ lotion.
  • Verva signs deals with two private biotechnology companies.
  • Otifex begins Phase 1b clinical study.
  • Hydrexia $4.25m investment for its hydrogen storage technology.
  • Progel launches novel probiotic drinks.
  • OccuRx launched with up to $6.5m in funding.
  • Tenasitech secures $509,269 Federal grant.

 

Click here to download your copy.

 

newsletter-june-2015

Save

Save

Save

Save

Save